Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.
Haruru KotaniNorikazu MasudaToshinari YamashitaYoichi NaitoTetsuhiko TairaKenichi InoueMasato TakahashiKan YonemoriShigeyuki ToyoizumiYuko MoriTakashi NagasawaNatsuki HoriHiroji IwataPublished in: Breast cancer (Tokyo, Japan) (2022)
NCT03343054.